top of page


Educate and engage patients with sarcopenia

Body composition is essential for understanding a patient’s makeup of muscle and fat and how this information drives health and disease risk. Deeper insight into body composition balance helps with guiding treatments and targeting specific areas for improvement to reverse or prevent functional impairment, sarcopenia and frailty. InBody devices are non-invasive and convenient, making it the ideal tool to implement into prevention and treatment programs. The InBody test provides comprehensive results that can be used to educate and engage patients about their health and risk for injury due to low muscle mass.

In less than 60 seconds, the InBody Test provides easy-to-understand, accurate and objective measurements to evaluate the patient’s current skeletal muscle mass and determine risk of sarcopenia or frailty. Physicians can use the InBody to:


  • Identify areas weakened through muscle loss that increase risk of health complications or falls

  • Assess muscle mass to determine muscle loss and regain through rehabilitation programs

  • Quantify health risk through the evaluation of body fat distribution

  • Track fluid imbalances related to loss of muscle mass, edema, or inflammation.

Identify risk of sarcopenia and decreased mobility

As we age, our bodies start to lose muscle mass; as more sedentary behavior is adopted, this rate of loss increases, exacerbating age-related risk of injury. However, identifying these age-related changes in muscle and how they relate to frailty risk are difficult to identify and track.

By accurately measuring fat-free mass in each segment of the body, Skeletal Muscle Index (SMI) easily identifies muscle mass and frailty risk.

Sarcopenia and frailty hinder the elderly population, affecting mortality, cognitive function, and quality of life. As the population continues to live longer, preservation of lean mass becomes an integral part of maintaining one’s independence and quality of life. Loss of muscle in the arms and legs is associated with reductions in mobility, increased risk of falls and frailty, and prolonged length of hospital stay. Falls and fractures frequently result in a cycle of muscle deterioration that negatively impacts patients’ physical function and independence. Using a noninvasive tool to track body composition changes, patients can be placed under close surveillance to minimize muscle wasting and risk of impaired mobility. Furthermore, assessing skeletal muscle mass in outpatient and hospital settings can decrease these debilitating outcomes before they occur.

InBody provides a quick, easy to perform test that provides a calculation for skeletal muscle index (SMI), the sum of the lean mass in the arms and legs, normalized for height. This marker is useful in identifying low muscle in the appendages, which increases frailty risk. The ease of performing the InBody test provides physicians with more time to work with and educate patients on adopting lifestyle changes to help prevent sarcopenia and loss of independence.

inbody-770-smi-1310x1536 (1).png

Are you wondering if a professional InBody device is right for you? We partner you with an InBody specialist that understands your industry and unique needs.

bottom of page